Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
This ribonuclease gene is a novel member of the Rh/T2/S-glycoprotein class of extracellular ribonucleases. Additionally we are shipping Ribonuclease T2 Kits (59) and Ribonuclease T2 Proteins (12) and many more products for this protein.
Showing 10 out of 64 products:
Dog (Canine) Polyclonal RNASET2 Primary Antibody for IHC, WB - ABIN2777766
Campomenosi, Salis, Lindqvist, Mariani, Nordström, Acquati, Taramelli: Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins. in Archives of biochemistry and biophysics 2006
Show all 2 Pubmed References
RNASET2 is the enzyme that degrades the RNAs
RNASET2, an IBD susceptibility gene, is a component of TL1A (show TNFSF15 Antibodies)-mediated pathways regulating cytokine production.
inhibits melanocyte outgrowth through interacting with shootin1 (show KIAA1598 Antibodies); this effect may be associated with vitiligo (show MITF Antibodies) pathogenesis
Biological features allow to put forward the hypothesis that the RNASET2 protein can act as a molecular barrier for limiting the damages and tissue remodeling events occurring during the earlier step of cell transformation.
RNASET2 may contribute to the development of vitiligo (show MITF Antibodies) by inhibiting TNF Receptor-Associated Factor 2 (show TRAF2 Antibodies) expression and lead directly to apoptosis of melanocytes
describe a multi-step strategy that allows production of highly pure, catalytically competent recombinant RNASET2 in both wild-type and mutant forms
RNASET2 has antitumorigenic and antiangiogenic activities; a truncated version of human RNASET2, starting at E50 (trT2-50) and devoid of ribonuclease activity, has actin binding and anticancer-related biological activities
RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population
Results show that downregulation of RNASET2 and GGNBP2 (show GGNBP2 Antibodies) in drug-resistant ovarian cancer tissues/cells contributes to the regulation of drug resistance in ovarian cancer.
RNASET2 contributes to vitiligo (show MITF Antibodies) pathogenesis by inhibiting TRAF2 (show TRAF2 Antibodies) expression.
This ribonuclease gene is a novel member of the Rh/T2/S-glycoprotein class of extracellular ribonucleases. It is a single copy gene that maps to 6q27, a region associated with human malignancies and chromosomal rearrangement.
, RNase Dre2
, ribonuclease t2
, ribonuclease 6
, polyU-preferential ribonuclease